HR 1416
114th Congress
House
Health
Cancer
Congressional oversight
Drug therapy
Government studies and investigations
Health facilities and institutions
Hospital care
Medicare
Cancer Patient Protection Act of 2015
Introduced: March 18, 2015
See on congress.gov
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 20, 2015
Referred to the Subcommittee on Health.
Mar 19, 2015
Referred to the Subcommittee on Health.
Mar 18, 2015
Referred to the Committee on the Budget, and in addition to the Committees on Ways and Means, and Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Mar 18, 2015
Introduced in House
Plain-English summary
Cancer Patient Protection Act of 2015
This bill requires any new presidential sequestration order for FY2016-FY2017 to declare that no reduction shall be made with respect to payments for physician-administered drugs and biologicals under part B (Supplementary Medical Insurance) of title XVIII (Medicare) of the Social Security Act to the extent that such payments are made based on their average sales price.
The Government Accountability Office must examine the shift of cancer care from physician-run community cancer clinics to hospitals and its consequences to costs to the federal government and to Medicare beneficiaries for cancer care under the Medicare program.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
5